Risk scoring methods continue to evolve with increased understanding of the factors that affect specific patient group outcomes in MDS. Diagnosis of MDS is currently based on morphology, but can be ...
A myeloid panel mutation analysis should be prioritized for patients with clonal cytopenia of undetermined significance (CCUS) as it can better assess patient risks for progression to a myeloid ...
Quantitative Integrative Survival Prediction in Multiple Myeloma Patients Treated With Bortezomib-Based Induction, High-Dose Therapy and Autologous Stem Cell Transplantation Of 37 patients enrolled, ...
A team of international scientists has developed a method to predict the risk of developing cancer from a blood disorder common in older adults, according to a study published in the journal Blood.
—Although clonal hematopoiesis of indeterminate potential has been linked to a higher risk for myeloid neoplasms and inflammatory diseases, not much is known about the individual risk of developing ...
Cytopenia in myelofibrosis patients increases the risk of AML progression and decreases overall survival, necessitating careful treatment selection. A retrospective cohort study found 70% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results